No-exam term life after basal cell carcinoma
After basal cell or squamous cell skin cancer, no-exam term life may still be possible. Learn what carriers No-exam term life after basal cell carcinoma.
-
Instant online pricing
-
No phone calls required
-
No pressure from agents
Basal vs Squamous: The Details Matter
Basal cell and squamous cell skin cancers are often underwritten differently than melanoma. Underwriters typically focus on the type, treatment, margins, and follow-up history.
Which skin cancer type you had (and why it matters)
Treatment details: excision, Mohs, margins, recurrence
How time since treatment can affect options
Skin cancer history can sound scary, but underwriting usually starts with one simple clarification: what type was it? Basal cell and squamous cell are typically treated differently than melanoma.
For no-exam programs, carriers may still ask follow-up questions about treatment and timing. They often want to know when it was treated, whether margins were clear, and whether there’s been any recurrence.
If it was a single, fully treated basal cell carcinoma years ago, underwriting is often more straightforward. More recent treatment, repeated occurrences, or higher-risk findings can trigger a deeper review.
When you compare quotes, make sure each quote is based on the same type and timing. “Skin cancer” is too broad - the details can shift the outcome.
Have your diagnosis type, treatment date, and follow-up schedule ready. It’s the quickest way to keep underwriting from stalling on missing information.
For the full instant/no-exam term life overview, see: https://www.careproinsurance.com/instant-term-life-insurance
Disclaimer: Educational information only - not medical, legal, or tax advice. Quotes are estimates and final decisions depend on underwriting and carrier guidelines.
Frequently Asked Questions
Can I get no-exam term life insurance after basal cell carcinoma?
Sometimes. Many carriers consider applicants after basal cell carcinoma, especially when it was fully treated and there’s been no recurrence. Guidelines vary by carrier and timing.
Is squamous cell carcinoma treated differently than basal cell?
Often, yes. Underwriters may view squamous cell as higher risk than basal cell, depending on the case. Treatment details and recurrence history are important.
What skin cancer information do carriers usually ask for?
Common questions include type (basal vs squamous vs melanoma), dates, treatment method (excision/Mohs), whether margins were clear, and whether there’s been recurrence.
How long after treatment should I wait to apply?
There isn’t a single rule. Some carriers are comfortable soon after successful treatment; others prefer a longer window. Timing depends on type and severity.
Does melanoma change things?
Yes. Melanoma is generally underwritten more strictly and often involves longer waiting periods or more requirements. Basal and squamous cases are typically evaluated differently.
Related Pages and Helpful Resources
Read the Full Guide Here:
Get Covered With The Right Plan
Make the skin cancer distinctions clear (basal vs squamous vs melanoma), and focus on treatment, margins, and follow-up timelines.
Check your term options